BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 30928109)

  • 1. Fontan-associated liver disease: A review.
    Gordon-Walker TT; Bove K; Veldtman G
    J Cardiol; 2019 Sep; 74(3):223-232. PubMed ID: 30928109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fontan-associated liver disease and hepatocellular carcinoma in adults.
    Kogiso T; Tokushige K
    Sci Rep; 2020 Dec; 10(1):21742. PubMed ID: 33303924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation.
    Inuzuka R; Nii M; Inai K; Shimada E; Shinohara T; Kogiso T; Ono H; Otsuki SI; Kurita Y; Takeda A; Hirono K; Takei K; Yasukohchi S; Yoshikawa T; Furutani Y; Shinozaki T; Matsuyama Y; Senzaki H; Tokushige K; Nakanishi T
    Heart; 2023 Jan; 109(4):276-282. PubMed ID: 35768191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
    Kuwabara M; Niwa K; Toyoda T; Shirai T; Tateno S; Ohuchi H; Tanaka Y; Ichida F; Fujisawa T; Akagi T; Mori Y;
    Circ J; 2018 Mar; 82(4):1155-1160. PubMed ID: 29445059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.
    Poterucha JT; Johnson JN; Qureshi MY; O'Leary PW; Kamath PS; Lennon RJ; Bonnichsen CR; Young PM; Venkatesh SK; Ehman RL; Gupta S; Smyrk TC; Dearani JA; Warnes CA; Cetta F
    Mayo Clin Proc; 2015 Jul; 90(7):882-94. PubMed ID: 26059757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fontan-associated liver disease: Implications for heart transplantation.
    Greenway SC; Crossland DS; Hudson M; Martin SR; Myers RP; Prieur T; Hasan A; Kirk R
    J Heart Lung Transplant; 2016 Jan; 35(1):26-33. PubMed ID: 26586487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fontan-associated liver disease current status and transplantation consideration].
    Liu X; Tu JZC; Teng Y; Chen JM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):109-112. PubMed ID: 36948859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for liver complications after the Fontan procedure.
    Hilscher MB; Johnson JN; Cetta F; Driscoll DJ; Poterucha JJ; Sanchez W; Connolly HM; Kamath PS
    Congenit Heart Dis; 2017 Mar; 12(2):124-132. PubMed ID: 28140526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver disease secondary to congenital heart disease in children.
    Komatsu H; Inui A; Kishiki K; Kawai H; Yoshio S; Osawa Y; Kanto T; Fujisawa T
    Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):651-666. PubMed ID: 31131680
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
    Téllez L; Rodríguez de Santiago E; Minguez B; Payance A; Clemente A; Baiges A; Morales-Arraez D; La Mura V; Llop E; Garrido E; Garrido-Lestache E; Tasayco S; Bruno O; Prieto R; Montserrat S; Pons M; Olavarría A; Dos L; Legendre A; Jesús Del Cerro M; Bañares R; García-Pagán JC; Rautou PE; Albillos A;
    J Hepatol; 2020 Apr; 72(4):702-710. PubMed ID: 31726116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in Accurate Diagnosis of HCC in FALD: A Case Series.
    Feeley M; Hopkins K; Grinspan LT; Schiano T; Love B; Chan A; Lewis S; Zaidi AN
    Pediatr Cardiol; 2023 Oct; 44(7):1447-1453. PubMed ID: 37318608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fontan circulation and the liver: A magnetic resonance diffusion-weighted imaging study.
    Wolff D; van Melle JP; Dijkstra H; Bartelds B; Willems TP; Hillege H; van den Berg AP; Ebels T; Sijens PE; Berger RM
    Int J Cardiol; 2016 Jan; 202():595-600. PubMed ID: 26447669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive ultrasound technique for assessment of liver fibrosis and cardiac function in Fontan-associated liver disease: diagnosis based on elastography and hepatic vein waveform type.
    Koizumi Y; Hirooka M; Tanaka T; Watanabe T; Yoshida O; Tokumoto Y; Higaki T; Eguchi M; Abe M; Hiasa Y
    J Med Ultrason (2001); 2021 Apr; 48(2):235-244. PubMed ID: 33417157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of hepatocellular carcinoma in Fontan patients: Review of the literature and suggestions for hepatic screening.
    Josephus Jitta D; Wagenaar LJ; Mulder BJ; Guichelaar M; Bouman D; van Melle JP
    Int J Cardiol; 2016 Mar; 206():21-6. PubMed ID: 26773766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
    Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
    Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplantation and Post-Transplantation Liver Disease Assessment in Adolescents Undergoing Isolated Heart Transplantation for Fontan Failure.
    Rodriguez DS; Mao C; Mahle WT; Kanter KR; Alazraki A; Braithwaite K; Rytting H; Caltharp S; Magliocca JF; Romero R
    J Pediatr; 2021 Feb; 229():78-85.e2. PubMed ID: 32976893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.
    Friedrich-Rust M; Koch C; Rentzsch A; Sarrazin C; Schwarz P; Herrmann E; Lindinger A; Sarrazin U; Poynard T; Schäfers HJ; Zeuzem S; Abdul-Khaliq H
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):560-7. PubMed ID: 18329470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.
    Possner M; Gordon-Walker T; Egbe AC; Poterucha JT; Warnes CA; Connolly HM; Ginde S; Clift P; Kogon B; Book WM; Walker N; Wagenaar LJ; Moe T; Oechslin E; Kay WA; Norris M; Dillman JR; Trout AT; Anwar N; Hoskoppal A; Broering DC; Bzeizi K; Veldtman G
    Int J Cardiol; 2021 Jan; 322():142-148. PubMed ID: 32828959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation.
    Hitawala AA; Gopalakrishna H; Mironova M; Livinski AA; Wright EC; Downing T; Ito S; Fisher SD; Cedars AM; John AS; Heller T
    Aliment Pharmacol Ther; 2024 May; 59(9):1020-1032. PubMed ID: 38497159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in two patients with cardiac cirrhosis.
    Saliba T; Dorkhom S; O'Reilly EM; Ludwig E; Gansukh B; Abou-Alfa GK
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):889-91. PubMed ID: 19550346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.